FindTrial
Sign In

Clinical utility of a model based on disulfidptosis-related lncRNAs in hepatocellular carcinoma with vascular invasion

Clinical utility of a model based on disulfidptosis-related lncRNAs in hepatocellular carcinoma with vascular invasion

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400090633
Enrollment
Unknown
Registered
2024-10-10
Start date
2024-10-12
Completion date
Unknown
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma

Interventions

Observation group:None

Sponsors

Jurong People Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients with a confirmed diagnosis of invasive hepatocellular carcinoma. 2. Aged between 18 and 75 years. 3. Willing to provide informed consent for participation in the study.

Exclusion criteria

Exclusion criteria: 1. Recently treated patients who have undergone other forms of cancer therapy. 2. Patients with concomitant severe systemic diseases.

Design outcomes

Primary

MeasureTime frame
Area Under the Curve;Receiver Operating Characteristic;C-index;Decision Curve Analysis;—

Countries

China

Contacts

Public ContactXuefeng Gu

Jurong People Hospital

guxuefeng@seu.edu.cn+86 181 3665 2720

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026